ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of...
111 insider purchases on record · latest filing 2023-05-24.
Insiders have also filed 353 sale transactions at ACAD.